Artal Group’s Instil Bio TIL Stock Holding History

Artal Group’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-22,500	Closed	-$284K	–	140
2022 Q4	$284K	Hold	22,500	–	–	0.02%	122
2022 Q3	$2.18M	Hold	22,500	–	–	0.09%	94
2022 Q2	$2.08M	Hold	22,500	–	–	0.11%	92
2022 Q1	$4.84M	Hold	22,500	–	–	0.2%	81
2021 Q4	$7.7M	Hold	22,500	–	–	0.21%	80
2021 Q3	$8.04M	Hold	22,500	–	–	0.18%	92
2021 Q2	$8.69M	Hold	22,500	–	–	0.18%	94
2021 Q1	$11.3M	Buy	+22,500	New	+$11.5M	0.2%	94

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Artal Group's TIL Position: Q1 2023 in Review

Artal Group sold out of Instil Bio (TIL) in Q1 2023, closing a stake of 22,500 shares — an estimated $284K sold.

Artal Group first reported a position in TIL in Q1 2021 and held it in 8 quarters. The position peaked at $11.3M in Q1 2021. 73 funds tracked by Wall St. Rank hold TIL as of Q1 2023.

Artal Group reported no remaining Instil Bio position as of Q1 2023 after selling out during the quarter.
Artal Group sold 22,500 Instil Bio shares in Q1 2023, an estimated $284K.
Artal Group first reported a position in Instil Bio in Q1 2021 and held it in 8 quarters.
Artal Group's Instil Bio position peaked at $11.3M in Q1 2021.
73 funds tracked by Wall St. Rank held Instil Bio as of Q1 2023.

Based on Artal Group's 13F filing for Q1 2023, filed 12 May 2023.